Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Жировой гепатоз как фактор сердечно-сосудистого риска
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–31.
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37 (5): 1202–19.
3. Blachier Martin, Leleu Henri, Peck-Radosavljevic Markus, Valla Dominique Charles and Roudot-Thoraval Françoise. The burden of liver disease in Europe: a review of available epidemiological data. ISBN No. 978-2-8399-1176-4.
4. Драпкина О.М., Смирин В.И., Ивашкин В.Т. Патогенез, лечение, эпидемиология НАЖБП – что нового? Эпидемиология НАЖБП в России. Русский медицинский журнал. 2011; 28: 717–22.
5. Misra Vijay Laxmi, Khashab Mouen, Chalasani Naga. Nonalcoholic fatty liver disease and cardiovascular risk. Curr Gastroenterol Rep 2009; 11: 50–5.
6. Targher G, Bertolini L, Padovani R et al. relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes care 2006; 29: 1325–30.
7. Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Artherosclerosis 2007; 191: 235–40.
8. Villanova N, Moscatiello S, Ramilli S et al. endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease. Hepatology 2005; 42: 473–78.
9. Targher G, Bertolini L, Padovani R et al. increased prevalence of cardiovascular disease among type 2 diabetic patients with nonalcoholic fatty liver disease. Diabet Med 2006; 23: 403–9.
10. Sun Ling and LÜ Shu-zheng. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chinese Medical Journal 2011; 124 (6): 867–72.
11. Mirbagheri SA, Rashidi A, Abdi S et al. Liver: an alarm for the heart? Liver Int 2007; 27: 891–4.
12. Goland S, Shimoni S, Zornitzki T et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006; 40: 949–55.
13. Perseghin G, Lattuada G, De Cobelli F et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008; 47: 51–8.
14. Kim SG, Kim HY, Seo JA et al. Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease. Eur J Endocrinology 2005; 152: 225–31.
15. Perseghin G. 2009, EASL Congress abstracts, p. 36.
16. Kessler A, Levy Y, Roth A et al. increased prevalence of NAFLD in patients with acute myocardial infarction independent of BMI. Hepatology 2005; 42: 623A.
17. Targher G, Bertolini L, Padovani R et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among Type 2 diabetic patients. Diabetes Care 2007; 30: 1212–8.
18. Lautama¨ki Riikka, Borra Ronald, Iozzo Patricia et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006; 291: 282–90.
19. Targher Giovanni, Christopher P. Day, Enzo Bonora. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. N Engl J Med 2010; 363: 1341–50.
20. Hamaguchi M, Kojima T, Takeda N et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13 (10): 1579–84.
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37 (5): 1202–19.
3. Blachier Martin, Leleu Henri, Peck-Radosavljevic Markus, Valla Dominique Charles and Roudot-Thoraval Françoise. The burden of liver disease in Europe: a review of available epidemiological data. ISBN No. 978-2-8399-1176-4.
4. Драпкина О.М., Смирин В.И., Ивашкин В.Т. Патогенез, лечение, эпидемиология НАЖБП – что нового? Эпидемиология НАЖБП в России. Русский медицинский журнал. 2011; 28: 717–22.
5. Misra Vijay Laxmi, Khashab Mouen, Chalasani Naga. Nonalcoholic fatty liver disease and cardiovascular risk. Curr Gastroenterol Rep 2009; 11: 50–5.
6. Targher G, Bertolini L, Padovani R et al. relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes care 2006; 29: 1325–30.
7. Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Artherosclerosis 2007; 191: 235–40.
8. Villanova N, Moscatiello S, Ramilli S et al. endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease. Hepatology 2005; 42: 473–78.
9. Targher G, Bertolini L, Padovani R et al. increased prevalence of cardiovascular disease among type 2 diabetic patients with nonalcoholic fatty liver disease. Diabet Med 2006; 23: 403–9.
10. Sun Ling and LÜ Shu-zheng. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chinese Medical Journal 2011; 124 (6): 867–72.
11. Mirbagheri SA, Rashidi A, Abdi S et al. Liver: an alarm for the heart? Liver Int 2007; 27: 891–4.
12. Goland S, Shimoni S, Zornitzki T et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006; 40: 949–55.
13. Perseghin G, Lattuada G, De Cobelli F et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008; 47: 51–8.
14. Kim SG, Kim HY, Seo JA et al. Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease. Eur J Endocrinology 2005; 152: 225–31.
15. Perseghin G. 2009, EASL Congress abstracts, p. 36.
16. Kessler A, Levy Y, Roth A et al. increased prevalence of NAFLD in patients with acute myocardial infarction independent of BMI. Hepatology 2005; 42: 623A.
17. Targher G, Bertolini L, Padovani R et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among Type 2 diabetic patients. Diabetes Care 2007; 30: 1212–8.
18. Lautama¨ki Riikka, Borra Ronald, Iozzo Patricia et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006; 291: 282–90.
19. Targher Giovanni, Christopher P. Day, Enzo Bonora. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. N Engl J Med 2010; 363: 1341–50.
20. Hamaguchi M, Kojima T, Takeda N et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13 (10): 1579–84.
Авторы
М.Е.Стаценко, С.В.Туркина
ФГБОУ ВПО Волгоградский государственный медицинский университет Минздрава РФ
ФГБОУ ВПО Волгоградский государственный медицинский университет Минздрава РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.